Scientific Research Review SURPASS Clinical Trial Program (Type 2 Diabetes) The SURPASS program comprised phase III trials evaluating tirzepatide 5, 10, and 15 mg once weekly in patients with type 2 diabetes: SURPASS-1 (monotherapy, n=478): Tirzepatide reduced HbA1c by 1.87% (5 mg), 1.89% (10 mg), and 2.07% (15 mg) vs
These medications are helping many people lose weight and manage their health, but how does alcohol fit into the picture
Breaking News for Lymphedema Care Could medications like Ozempic and Wegovy reduce lymphedema swelling
other flavors and fatty acids
In many advanced cancers, telomerase is reactivated, and both very short and very long telomere states have been linked to disease risk in different contexts
Recapping its benefits, Glutaone Facewash not only cleanses the skin but also brightens, soothes, and protects, making it a versatile addition to any skincare routine